Boosting endocannabinoid 2-AG protected against stomach bleeding caused by common painkillers in mice
The MAGL inhibitor JZL184 prevented NSAID-induced gastric hemorrhages in mice as effectively as the proton pump inhibitor omeprazole, working through the CB1 receptor without developing tolerance.
Quick Facts
What This Study Found
NSAIDs (common painkillers like ibuprofen) frequently cause stomach bleeding and ulcers. Researchers tested whether boosting levels of the endocannabinoid 2-AG by inhibiting its breakdown enzyme MAGL could protect the stomach.
In mice given the NSAID diclofenac, the MAGL inhibitor JZL184 significantly prevented gastric hemorrhages, as effectively as the proton pump inhibitor omeprazole (a standard gastroprotective drug) and THC.
JZL184 also completely blocked diclofenac-induced increases in pro-inflammatory cytokines (IL-1-beta, IL-6, TNF-alpha) in stomach tissue. The protective effect worked through CB1 receptors specifically, as shown by both pharmacological blockade and genetic knockout experiments.
Importantly, the gastroprotective effects of JZL184 persisted with repeated administration, showing no tolerance development.
Key Numbers
JZL184 matched omeprazole and THC effectiveness. Completely blocked diclofenac-induced increases in IL-1-beta, IL-6, TNF-alpha, and G-CSF. Gastroprotection mediated by CB1 (not CB2). No tolerance with repeated dosing.
How They Did This
Controlled animal study in mice. Diclofenac-induced gastric hemorrhage model. JZL184 (MAGL inhibitor), omeprazole, and THC tested as interventions. Inflammatory cytokines measured. CB1 and CB2 receptor involvement tested using antagonists and knockout mice. Repeated dosing tested for tolerance.
Why This Research Matters
NSAIDs cause significant GI complications. A gastroprotective agent based on the endocannabinoid system could potentially be combined with NSAIDs to prevent stomach damage while maintaining pain relief.
The Bigger Picture
MAGL inhibition could potentially produce analgesics with built-in gastroprotective properties, addressing a major limitation of current NSAID therapy.
What This Study Doesn't Tell Us
Mouse model. JZL184 is a research tool not approved for human use. Only one NSAID (diclofenac) tested. Long-term safety of MAGL inhibition in the GI tract is unknown.
Questions This Raises
- ?Could MAGL inhibitors be developed as dual analgesic-gastroprotective drugs?
- ?Would the gastroprotective effect translate to humans?
Trust & Context
- Key Stat:
- MAGL inhibitor matched standard gastroprotection without tolerance
- Evidence Grade:
- Well-designed animal study with mechanistic validation using knockouts and antagonists, but limited to mouse models.
- Study Age:
- Published in 2011. MAGL inhibitor drug development has continued.
- Original Title:
- Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 338(3), 795-802 (2011)
- Authors:
- Kinsey, Steven G(12), Nomura, Daniel K(4), O'Neal, Scott T(2), Long, Jonathan Z, Mahadevan, Anu, Cravatt, Benjamin F, Grider, John R, Lichtman, Aron H
- Database ID:
- RTHC-00497
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could endocannabinoids protect the stomach from painkiller damage?
In mice, boosting the endocannabinoid 2-AG protected against stomach bleeding from NSAIDs as effectively as standard gastroprotective drugs, working through CB1 receptors and blocking inflammatory cytokines.
What is MAGL?
MAGL (monoacylglycerol lipase) is the enzyme that breaks down 2-AG, one of the body's main endocannabinoids. Blocking MAGL increases 2-AG levels, boosting the endocannabinoid system's protective effects.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- cannabis-and-arthritis-research
Cite This Study
https://rethinkthc.com/research/RTHC-00497APA
Kinsey, Steven G; Nomura, Daniel K; O'Neal, Scott T; Long, Jonathan Z; Mahadevan, Anu; Cravatt, Benjamin F; Grider, John R; Lichtman, Aron H. (2011). Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.. The Journal of pharmacology and experimental therapeutics, 338(3), 795-802. https://doi.org/10.1124/jpet.110.175778
MLA
Kinsey, Steven G, et al. "Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.." The Journal of pharmacology and experimental therapeutics, 2011. https://doi.org/10.1124/jpet.110.175778
RethinkTHC
RethinkTHC Research Database. "Inhibition of monoacylglycerol lipase attenuates nonsteroida..." RTHC-00497. Retrieved from https://rethinkthc.com/research/kinsey-2011-inhibition-of-monoacylglycerol-lipase
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.